Managed Account Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q2 | $222M | Buy |
1,227,510
+169,272
| +16% | +$30.6M | 0.18% | 146 |
|
|
2015
Q1 | $183M | Buy |
1,058,238
+174,043
| +20% | +$30.2M | 0.16% | 161 |
|
|
2014
Q4 | $164M | Buy |
884,195
+129,348
| +17% | +$23.9M | 0.16% | 160 |
|
|
2014
Q3 | $125M | Buy |
754,847
+10,369
| +1% | +$1.72M | 0.14% | 179 |
|
|
2014
Q2 | $116M | Buy |
744,478
+80,328
| +12% | +$12.6M | 0.14% | 178 |
|
|
2014
Q1 | $101M | Sell |
664,150
-29,395
| -4% | -$4.47M | 0.13% | 187 |
|
|
2013
Q4 | $92.2M | Buy |
693,545
+21,227
| +3% | +$2.82M | 0.12% | 204 |
|
|
2013
Q3 | $78.1M | Sell |
672,318
-99,019
| -13% | -$11.5M | 0.11% | 216 |
|
|
2013
Q2 | $71.1M | Buy |
+771,337
| New | +$71.1M | 0.11% | 219 |
|